首页> 外文期刊>BMC Complementary and Alternative Medicine >A novel kefir product (PFT) inhibits Ehrlich ascites carcinoma in mice via induction of apoptosis and immunomodulation*
【24h】

A novel kefir product (PFT) inhibits Ehrlich ascites carcinoma in mice via induction of apoptosis and immunomodulation*

机译:一种新的Kefir产品(PFT)通过诱导细胞凋亡和免疫调节抑制小鼠的EHRLICH腹水癌

获取原文
获取外文期刊封面目录资料

摘要

The popularity of fermented foods such as kefir, kuniss, and tofu has been greatly increasing over the past several decades, and the ability of probiotic bacteria to exert anticancer effects has recently become the focus of research. While we have recently demonstrated the ability of the novel kefir product PFT (Probiotics Fermentation Technology) to exert anticancer effects in vitro, here we demonstrate its ability to inhibit Ehrlich ascites carcinoma (EAC) in mice. Mice were inoculated intramuscularly with EAC cells to develop solid tumors. PFT was administered orally (2?g/kg/day) to mice 6?days/week, either 2 days before tumor cell inoculation or 9 days after inoculation to mice bearing solid tumors. Tumor growth, blood lymphocyte levels, cell cycle progression, apoptosis, apoptotic regulator expression, TNF-α expression, changes in mitochondrial membrane potential (MMP), PCNA, and CD4 and CD8 T cells in tumor cells were quantitatively evaluated by flow cytometry or RT-PCR. Further studies in vitro were carried out where EAC cells along with several other human cancer cell lines were cultured in the presence of PFT (0–5?mg/mL). Percent cell viability and IC50 was estimated by MTT assay. Our data shows that PFT exerts the following: 1) inhibition of tumor incidence and tumor growth; 2) inhibition of cellular proliferation via a marked decrease in the expression of tumor marker PCNA; 3) arrest of the tumor cell cycle in the sub-G0/G1 phase, signifying apoptosis; 4) induction of apoptosis in cancer cells via a mitochondrial-dependent pathway as indicated by the up-regulation of p53 expression, increased Bax/Bcl-2 ratio, decrease in the polarization of MMP, and caspase-3 activation; and 5) immunomodulation with an increase in the number of infiltrating CD4 and CD8 T cells and an enhancement of TNF-α expression within the tumor. PFT reduces tumor incidence and tumor growth in mice with EAC by inducing apoptosis in EAC cells via the mitochondrial-dependent pathway, suppressing cancer cell proliferation, and stimulating the immune system. PFT may be a useful agent for cancer prevention.
机译:在过去的几十年里,发酵食品等发酵食品的普及在过去的几十年里一直在大大增加,并且益生菌的能力最近成为研究的重点。虽然我们最近证明了新型Kefir产品PFT(益生菌发酵技术)在体外发挥抗癌效果的能力,但在这里,我们证明了其在小鼠中抑制Ehrlich腹水癌(EAC)的能力。用EAC细胞接种小鼠以形成实体瘤。将PFT口服(2?G / kg /天)给小鼠6?天/周,在肿瘤细胞接种前2天或接种到携带实体瘤的小鼠后9天。肿瘤生长,血液淋巴细胞水平,细胞周期进展,细胞凋亡,凋亡调节剂表达,TNF-α表达,线粒体膜电位(MMP),PCNA和CD4和CD8 T细胞的变化,通过流式细胞术或室温进行定量评估-PCR。进行体外进一步研究,其中在PFT(0-5×Mg / ml)存在下培养EAC细胞与其他几种人类癌细胞系进行培养。 MTT测定估计细胞活力和IC50百分比。我们的数据显示PFT施加以下内容:1)抑制肿瘤发病率和肿瘤生长; 2)通过肿瘤标志物PCNA表达的显着降低抑制细胞增殖; 3)在亚g0 / g1相中停止肿瘤细胞周期,意味着细胞凋亡; 4)通过线粒体依赖性途径诱导癌细胞的凋亡,如P53表达的上调,增加的Bax / Bcl-2比,MMP的偏振减少,并Caspase-3活化; 5)免疫调节随着渗透CD4和CD8 T细胞的数量增加以及肿瘤内的TNF-α表达的增加。通过线粒体依赖性途径诱导对小鼠的小鼠肿瘤发病率和肿瘤生长减少了小鼠的肿瘤发病率和肿瘤生长,抑制癌细胞增殖,刺激免疫系统。 PFT可能是癌症预防的有用药剂。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号